Glow LifeTech Corp.

Recent News

  • Glow LifeTech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview

    Toronto, Ontario--(Newsfile Corp. - October 14, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide an update on new appointments to support the Company's advancing manufacturing and commercial initiatives including the appointment of Josh Bald, CPA as Glow's dedicated CFO. As with many industries, Glow's setup of manufacturing and production related operations have been delayed due to supply shortages stemming from the COVID-19 pandemic. The Company now anticipates that these...

    2021-10-14 3:46 PM EDT
  • Glow LifeTech Announces Upgrade to OTCQB Under Ticker 'GLWLF'

    Toronto, Ontario--(Newsfile Corp. - August 16, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce that after successfully completing the application process, the Company has received approval from OTC Markets Group Inc. for its common shares to begin trading on the OTCQB Market ("OTCQB") under the symbol "GLWLF". The Company's common shares will remain listed on the CSE...

    2021-08-16 8:56 PM EDT
  • Glow Acquires Strategic Equity Investment in Nova Mentis

    Toronto, Ontario--(Newsfile Corp. - August 10, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce a strategic investment into Nova Mentis1 ("Nova").The Company purchased 854,000 shares in Nova at an average cost of $0.12 CAD.Nova Mentis Life Science Corp. is a Canadian-based biotechnology company and global leader in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Their goal is to diagnose and...

    2021-08-10 9:45 PM EDT
  • Glow LifeTech Secures Canadian Processing Facility, Begins Build-out to Produce Next-Generation Cannabis Ingredients

    Toronto, Ontario--(Newsfile Corp. - May 28, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech innovator producing next-generation, science-backed natural ingredients, is pleased to report that the Company has commenced the build-out and commissioning of licensed processing space ("Processing Space") to bring a suite of fast-acting, high-absorption, water-soluble cannabis-based ingredients to the Canadian market. The Processing Space is licensed for the processing and sale of cannabis under the Canadian Cannabis Act.Glow's MyCell® technology is...

    2021-05-28 3:00 AM EDT
  • Glow LifeTech Reports on Additional Research Results on ArtemiC and Positive Implications for COVID-19 Variants

    Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to report on further positive findings from the Phase II clinical and preclinical studies of ArtemiC™, evaluating its efficacy as an anti-inflammatory agent to counter increased cytokine production found in COVID-19 infections including different variants.

    2021-05-11 3:00 AM EDT
  • Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand

    Toronto, Ontario--(Newsfile Corp. - May 4, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FWB: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC™ at its supply partner, Swiss PharmaCan AG ("SPC") in April 20211, and a second production run worth nearly $1 million2 CAD that is scaled to service the growing demand around the world.

    2021-05-04 5:00 PM EDT
  • Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial

    Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce it submitted on Mar 11, 2021 an application to Health Canada to obtain product licenses for its Natural Health Product (NHP), ArtemiC™, which recently reported successful results from a COVID-19 Phase II clinical trial1.

    2021-04-27 5:00 PM EDT
  • Glow LifeTech to Commence Trading on the CSE on March 15, 2021 Under the Symbol "GLOW"

    Toronto, Ontario--(Newsfile Corp. - March 12, 2021) - Glow LifeTech Corp. (formerly, Ateba Resources Inc.) (the "Company") is pleased to announce that the common shares of the Company will commence trading on the Canadian Securities Exchange ("CSE") effective at the open of business on March 15, 2021, under the symbol "GLOW". Clark Kent, CEO of the Company, commented, "Our public listing on the CSE is an important step forward for Glow and our shareholders, providing us with a broad platform...

    2021-03-12 8:30 AM EST